[Dopamine beta hydroxylase gene polymorphism and Parkinson's disease]

Area of Science:

• Neurogenetics
• Human Genetics
• Disease Susceptibility

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder with complex etiology.
• Genetic factors are implicated in PD pathogenesis.
• The dopamine beta hydroxylase (DBH) gene plays a role in neurotransmitter synthesis.

Purpose of the Study:

• To examine the association between dopamine beta hydroxylase (DBH) gene polymorphism and Parkinson's disease (PD) susceptibility.
• To investigate the role of specific DBH gene alleles and genotypes in PD risk within the Shanghai Chinese Han population.

Main Methods:

• An association study was conducted involving 144 PD patients and 188 healthy controls.
• Participants were matched for age, sex, and origin.
• DBH gene polymorphism was analyzed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).

Main Results:

• The allelic frequency of the A2 allele of the DBH gene was significantly higher in PD patients compared to controls (P<0.01).
• Individuals carrying the A2 allele had an increased risk of developing PD (OR=1.82).
• The genotypic frequency of A2/A2 was significantly higher in PD patients (OR=2.11, P<0.01), whereas A1 allele and A1/A2 genotype frequencies were lower (A1 alleles: OR=0.54, P<0.01; A1/A2 genotypes: OR=0.45, P<0.01).

Conclusions:

• Polymorphism in the DBH gene is associated with PD susceptibility in the Shanghai Chinese Han population.
• The A2 allele of the DBH gene may confer an increased risk for PD.
• The A1 allele might have a protective effect against PD in this population.